Biggest AstraZeneca jab maker unlikely to resume exports ‘for at least three months’

The world’s biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India’s coronavirus crisis.

Scroll to top